Form 8-K - Current report:
SEC Accession No. 0001477932-24-006352
Filing Date
2024-10-10
Accepted
2024-10-10 17:29:23
Documents
15
Period of Report
2024-10-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bglc_8k.htm   iXBRL 8-K 59467
  Complete submission text file 0001477932-24-006352.txt   192308

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bglc-20241004.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bglc-20241004_lab.xml EX-101.LAB 15716
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bglc-20241004_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bglc-20241004_pre.xml EX-101.PRE 9984
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bglc-20241004_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT bglc_8k_htm.xml XML 4191
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 1-307-241-6898
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

EIN.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41750 | Film No.: 241365945
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)